MAY 30, 2018 5:21 AM PDT

Non-Diet Therapy For PKU

WRITTEN BY: Nouran Amin

Phenylketonuria (PKU) is a rare inherited disorder that results an amino acid known as phenylalanine to build up in the body.

 

PKU is caused by a mutation in the gene responsible for producing the enzyme needed to break down phenylalanine. Without the enzyme, a toxic buildup can develop for individuals with PKU when they ingest foods that contain protein or aspartame; eventually leading to serious health complications. Babies born in the United States and many other countries are screened for PKU after birth, in order to recognize it right away and avoid any major health problems. For the rest of their lives, individuals with PKU — babies, children, and adults — must follow a strict diet that is phenylalanine-free.

Until this most recently, one of the only non-diet treatment options for individuals of PKU consisted of replacement cofactor; BioMarin’s Kuvan (sapropterin dihydrochloride). Kuvan binds to and enhances the activity of phenylalanine hydroxylase (PAH), an enzyme that metabolizes phenylalanine. “While Kuvan has been helpful to some people, it doesn't really benefit the large portion of our community, and many of those people are still struggling,” states Christine Brown, executive director of the National PKU Alliance (NPKUA), a nonprofit patient advocacy group, and the mother of two boys with PKU, “For most people, even on Kuvan, they still have to take medical foods.” Now, the FDA has recently approved another non-diet therapy: an enzyme substitute known as pegvaliase (Palynziq).

Palynziq metabolizes phenylalanine, replacing the deficient PAH enzyme that in PKU patients. “It is great that the FDA has approved . . . [Palynziq],” writes Francjan van Spronsen, a pediatrician specializing in inherited metabolic diseases at the University of Groningen in the Netherlands. “We have heard very promising results [that patients’] whole lives have changed, as now at least some of them can do without [specialized] diets or have increased their phenylalanine tolerance to a large degree.” As of now, Palynziq is only approved for use in the U.S and only for adult patients with uncontrolled phenylalanine amounts. Palynziq also comes with a black box warning due to the risk of anaphylaxis, which is severe and may be fatal allergic reaction if not treated. BioMarin has stated has announced that the therapy is expected to cost approximately $192,000 per year.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
MAY 25, 2020
Drug Discovery & Development
MAY 25, 2020
Hydrochloroquine Increases Risk of Death by COVID-19
Researchers have found that hydroxychloroquine is not an effective treatment for COVID-19. Their study found that it lea ...
MAY 26, 2020
Drug Discovery & Development
MAY 26, 2020
Everyone Can Produce Antibodies Against COVID-19
Researchers at Rockefeller University in New York have found that most people exposed to COVID-19, and who experience sy ...
MAY 28, 2020
Cancer
MAY 28, 2020
The Oncogenic Hazard of a Potential Alzheimer's Treatment
Breast cancer remains one of the most common cancers around the world. Triple-Negative Breast Cancer (TNBC) is a sub-typ ...
JUN 13, 2020
Cancer
JUN 13, 2020
Examining Cancers Effect on the Immune System for Prognostic Use
Most think of cancer in the context of where it is on the body like breast or pancreatic cancer. There are several more ...
JUN 19, 2020
Drug Discovery & Development
JUN 19, 2020
First Treatment To Prevent Anaphylaxis
People living with food or drug allergies are always faced with potential life-threatening anaphylactic shock. Currently ...
Loading Comments...